Recent Quotes (30 days)

You have no recent quotes
chg | %

Angel Biotechnology Holdings Plc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

ABH 0.0500
price chart
Angel Biotechnology calls in administrators
The company has a subsidiary, Angel Biomedical, which is also in administration. Share-trading in AIM-listed Angel Biotechnology Holdings has ceased. KPMG said the companies had incurred losses, most recently as a result of difficult trading conditions.
Related articles »  
18 June 2015. 6pm
The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canap� and wine reception.
23 April 2015. 6pm
The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canap� and wine reception.
Related articles »  
Festive Features: Hybridan analyst Nathan on what to look for in a biotech ...
Derren Nathan, lead analyst at Hybridan, says there is demand from investors for companies with revenues and diversified later-stage portfolios.
12 March 2015. 6pm
The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canap� and wine reception.
SMALL CAP MOVERS: Kibo, Hummingbird and Beowulf lead junior mining firms ...
Oil's headline-hogging demise must have felt like a godsend to small cap mining companies peddling wares in London this week, as the black stuff has overshadowed 2014's other faltering commodities.
Related articles »  
Biotech.s hot streak not yet ready to cool
And juniors RetroScreen Virology (LON:RVG), which secured �33mln in August, and Benchmark Holdings (LON:BMK), which raised �70mln in November, saw plenty of interest in their respective stories.
Quindell car crash worsens after clarification statement
On Guy Fawkes Day, the company revealed that three directors had borrowed money from Equities First Holdings (EFH), using their existing shareholdings in Quindell as collateral, to finance the purchase of further Quindell shares.
Related articles »  
UPDATE - Epistem Holdings completes successful clinical test of Genedrive in ...
Epistem (LON:EHP) has passed a major milestone in India with the successful completion of a clinical evaluation study of its flagship Genedrive diagnostic device.
Related articles »  
UPDATE - Swiss franc chaos claims FX brokerage scalps; banks hit
The Swiss National Bank's (SNB) decision to remove its currency peg to the euro is crushing foreign exchange brokers around the globe.